# Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome

> **NCT01599169** · NA · COMPLETED · sponsor: **Université Victor Segalen Bordeaux 2** · enrollment: 87 (actual)

## Conditions studied

- Efficacy and Tolerance of B-Back® on the Burnout Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Dietary supplement : B-Back® (α-casozepine, taurine, eleutherococcus senticosus, Extramel)
- **DIETARY_SUPPLEMENT:** B-Back® placebo (without active compounds)

## Key facts

- **NCT ID:** NCT01599169
- **Lead sponsor:** Université Victor Segalen Bordeaux 2
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2013-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01599169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01599169, "Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01599169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*